January 01, 1996 book-chapter Open access Virus isolation and quantitation Elsevier eBooks DOI: 10.1016/b978-012465330-6/50003-8 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 11 stored of 428 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Decreased Fc fucosylation aligns with enhanced RSV-specific antibody functionality in adults compared to young children 2025 Communications Medicine article Medicine Respiratory viral infections research Open access 1 citations Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity 2024 Scientific Reports article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 2 patents 16 citations Difference in respiratory syncytial virus-specific Fc-mediated antibody effector functions between children and adults 2023 Clinical & Experimental Immunology article Medicine Respiratory viral infections research Open access 16 citations Absence of rapid T cell control corresponds with delayed viral clearance in hospitalised COVID-19 patients 2021 Research Square preprint Medicine COVID-19 Clinical Research Studies Open access 1 citations Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP 2021 The Journal of Experimental Medicine article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 6 patents 71 citations Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease 2021 npj Vaccines article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 18 patents 45 citations Immunogenicity and protective efficacy of one- and two-dose regimens of the Ad26.COV2.S COVID-19 vaccine candidate in adult and aged rhesus macaques 2020 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine SARS-CoV-2 and COVID-19 Research Open access 10 citations Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses 2020 npj Vaccines article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 21 patents 357 citations Ad26-vector based COVID-19 vaccine encoding a prefusion stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses 2020 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 21 patents 45 citations Natural killer cell activation by respiratory syncytial virus‐specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc‐glycosylation 2020 Clinical & Translational Immunology article Medicine Respiratory viral infections research Open access 37 citations Natural killer cell activation by respiratory syncytial virus-specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc-glycosylation 2020 Utrecht University Repository (Utrecht University) article Medicine Respiratory viral infections research Open access 0 citations 11 results References 0